European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.

As part of the European Multicentre Association Study of Schizophrenia (EMASS), we studied polymorphisms in the dopamine DRD2 and DRD3 receptor genes. The EMASS collaboration was established to create a large, statistically powerful sample of schizophrenic patients and controls from different European centres. Previous studies have suggested associations between schizophrenia and the Ser311Cys polymorphism in exon 7 of the dopamine DRD2 receptor gene [Arinami et al., (1994): Lancet 343:703-704] and a polymorphism Ser9gly in exon 1 of the dopamine DRD3 receptor gene [Crocq et al. (1992): J Med Genet 29:858-860]. We tested for these associations in samples of 373 and 413, and 311 and 306 patients and controls, respectively. We found no evidence for allelic association between schizophrenia and the Cys311 variant of the DRD2 receptor gene and no homozygotes for this variant were observed by any group. However, an excess of homozygotes for both alleles of the DRD3 polymorphism was observed in schizophrenic patients (chi2 = 8.54, P = 0.003, odds ratio = 1.64, 95% CI = 1.18-2.29). We also observed a significant excess of the 1-1 (Ser9Ser) genotype (chi2 = 8.13, P = 0.004, odds ratio = 1.7, 95% CI = 1.18-2.4). No evidence of heterogeneity between samples was detected and there was no evidence of an allelic association. These findings suggest that the rare Cys311 variant in exon 7 of the DRD2 receptor gene does not play a role in the pathogenesis of schizophrenia in European populations. Currently, our results do support the previous findings of an association between increased homozygosity of the Ser/Gly variant of the Dopamine D3 receptor gene and schizophrenia.

[1]  D. Sibley,et al.  Functional Analysis of the Human D2 Dopamine Receptor Missense Variants* , 1996, The Journal of Biological Chemistry.

[2]  R. Bradley,et al.  Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. , 1996, American journal of medical genetics.

[3]  M. P. Turpin,et al.  Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. , 1996, Biochemical and biophysical research communications.

[4]  H. Hwu,et al.  No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. , 1996, American journal of medical genetics.

[5]  A. Farmer,et al.  A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system , 1996, Psychological Medicine.

[6]  M. Itokawa,et al.  Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. , 1996, American journal of medical genetics.

[7]  C. Gerfen,et al.  A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. McGuffin,et al.  Genetic basis of schizophrenia , 1995, The Lancet.

[9]  H. Fibiger,et al.  Receptor mechanisms mediating clozapine-inducedc-fos expression in the forebrain , 1995, Neuroscience.

[10]  S. Cichon,et al.  Dopamine D2 receptor molecular variant and schizophrenia , 1994, The Lancet.

[11]  D. Collier,et al.  DRD2 Ser311/Cys311 polymorphism in schizophrenia , 1994, The Lancet.

[12]  M. Itokawa,et al.  Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.

[13]  M. Owen,et al.  Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. , 1994, American journal of medical genetics.

[14]  J. Mallet,et al.  Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. , 1994, Journal of medical genetics.

[15]  A. Chakravarti,et al.  Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history of schizophrenia? , 1993, American journal of medical genetics.

[16]  M. Itokawa,et al.  A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.

[17]  K. Davis,et al.  Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Owen,et al.  Association and linkage: complementary strategies for complex disorders. , 1993, Journal of medical genetics.

[19]  S. Cichon,et al.  Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed. , 1993, Journal of medical genetics.

[20]  P. Sokoloff,et al.  Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene , 1993, Acta psychiatrica Scandinavica.

[21]  D. Collier,et al.  Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. , 1992, Journal of medical genetics.

[22]  M. Martres,et al.  Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders , 1992 .

[23]  M. Martres,et al.  The third dopamine receptor (D3) as a novel target for antipsychotics. , 1992, Biochemical pharmacology.

[24]  M. Martres,et al.  The D3 Dopamine Receptor Gene as a Candidate Gene for Genetic Linkage Studies , 1992 .

[25]  A. Farmer,et al.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. , 1991, Archives of general psychiatry.

[26]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[27]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[28]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[29]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[30]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[31]  A Carlsson,et al.  The current status of the dopamine hypothesis of schizophrenia. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[32]  P. McGuffin,et al.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. , 1987, Archives of general psychiatry.

[33]  D. O’Rourke,et al.  Refutation of the general single-locus model for the etiology of schizophrenia. , 1982, American journal of human genetics.

[34]  D. Janowsky,et al.  Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. , 1976, Archives of general psychiatry.

[35]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Snyder,et al.  Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. , 1973, The American journal of psychiatry.

[37]  J. Shields,et al.  A polygenic theory of schizophrenia , 1967 .

[38]  B. Woolf.  ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.